And the MOG-IgG has been detected in about 40% of the patients of NMOSDs without the AQP4-IgG which might be classified as MOG-EM.[1,9,10] In previous studies, no significant agitating or inducing diseases associated with demyelinating MOG antibodies have been found. This evidence concerns the gene AQP4 and erythema multiforme.